{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:09:16Z","timestamp":1792440556776,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"DOI":"10.1186\/s44158-025-00304-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T09:05:37Z","timestamp":1763370337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analgesic and sedative drug dosing in critically ill patients with Acute Kidney Injury undergoing different modalities of Kidney Replacement Therapy"],"prefix":"10.1186","volume":"5","author":[{"given":"Francesca","family":"Di Mario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Regolisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Pacchiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Di Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Picetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Petranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pistolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uberto","family":"Percudani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"304_CR1","doi-asserted-by":"publisher","unstructured":"Li PK, Burdmann EA, Mehta RL, World Kidney Day Steering C Acute kidney injury: global health alert. Kidney Int. 2013;83(3):372-6. https:\/\/doi.org\/10.1038\/ki.2012.427","DOI":"10.1038\/ki.2012.427"},{"key":"304_CR2","doi-asserted-by":"publisher","unstructured":"Uchino S, Kellum JA, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-8. https:\/\/doi.org\/10.1001\/jama.294.7.813","DOI":"10.1001\/jama.294.7.813"},{"issue":"10","key":"304_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste EAJ, Kellum JA, Selby NM et al (2018) Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 14(10):607\u2013625. https:\/\/doi.org\/10.1038\/s41581-018-0052-0","journal-title":"Nat Rev Nephrol"},{"key":"304_CR4","unstructured":"(KDIGO), Kidney Disease: Improving Global Outcomes. Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012, Suppl S2:1\u2013138"},{"issue":"5","key":"304_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1053\/j.ajkd.2013.02.350","volume":"61","author":"M James","year":"2013","unstructured":"James M, Bouchard J, Ho J et al (2013) Canadian society of nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61(5):673\u201385. https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.350","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"304_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/j.ajkd.2024.09.015","volume":"85","author":"JP Teixeira","year":"2025","unstructured":"Teixeira JP, Hiremath S, Kabli AO, Rewa OG, Clark EG (2025) Continuous kidney replacement therapies: core curriculum 2025. Am J Kidney Dis 85(6):767\u2013786. https:\/\/doi.org\/10.1053\/j.ajkd.2024.09.015","journal-title":"Am J Kidney Dis"},{"key":"304_CR7","doi-asserted-by":"publisher","unstructured":"VA\/NIH Acute Renal Failure Trial Network; Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20. https:\/\/doi.org\/10.1056\/NEJMoa0802639","DOI":"10.1056\/NEJMoa0802639"},{"key":"304_CR8","doi-asserted-by":"publisher","unstructured":"RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627-38. https:\/\/doi.org\/10.1056\/NEJMoa0902413","DOI":"10.1056\/NEJMoa0902413"},{"issue":"4","key":"304_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s40620-020-00864-4","volume":"34","author":"F Di Mario","year":"2021","unstructured":"Di Mario F, Regolisti G, Greco P et al (2021) Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring. J Nephrol 34(4):1271\u20131279. https:\/\/doi.org\/10.1007\/s40620-020-00864-4","journal-title":"J Nephrol"},{"issue":"12","key":"304_CR10","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/ndt\/gfac159","volume":"37","author":"F Di Mario","year":"2022","unstructured":"Di Mario F, Regolisti G, Maggiore U et al (2022) Hypophosphatemia in critically ill patients undergoing sustained low-efficiency dialysis with standard dialysis solutions. Nephrol Dial Transplant 37(12):2505\u20132513. https:\/\/doi.org\/10.1093\/ndt\/gfac159","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"304_CR11","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/ndt\/gfad068","volume":"38","author":"F Di Mario","year":"2023","unstructured":"Di Mario F, Sabatino A, Regolisti G et al (2023) Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance. Nephrol Dial Transplant 38(10):2298\u20132309. https:\/\/doi.org\/10.1093\/ndt\/gfad068","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"304_CR12","doi-asserted-by":"publisher","first-page":"e00583\u201319","DOI":"10.1128\/AAC.00583-19","volume":"63","author":"V Pistolesi","year":"2019","unstructured":"Pistolesi V, Morabito S, Di Mario F, Regolisti G, Cantarelli C, Fiaccadori E (2019) A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy. Antimicrob Agents Chemother 63(8):e00583-19. https:\/\/doi.org\/10.1128\/AAC.00583-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"304_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.kint.2018.03.026","volume":"94","author":"M Ghannoum","year":"2018","unstructured":"Ghannoum M, Hoffman RS, Gosselin S, Nolin TD, Lavergne V, Roberts DM (2018) Use of extracorporeal treatments in the management of poisonings. Kidney Int 94(4):682\u2013688. https:\/\/doi.org\/10.1016\/j.kint.2018.03.026","journal-title":"Kidney Int"},{"issue":"11","key":"304_CR14","doi-asserted-by":"publisher","first-page":"EVIDra2300347","DOI":"10.1056\/EVIDra2300347","volume":"3","author":"KA Northam","year":"2024","unstructured":"Northam KA, Phillips KM (2024) Sedation in the ICU. NEJM Evid 3(11):EVIDra2300347. https:\/\/doi.org\/10.1056\/EVIDra2300347","journal-title":"NEJM Evid"},{"issue":"9","key":"304_CR15","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46(9):e825\u2013e873. https:\/\/doi.org\/10.1097\/CCM.0000000000003299","journal-title":"Crit Care Med"},{"issue":"2","key":"304_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1378\/chest.07-2026","volume":"133","author":"CN Sessler","year":"2008","unstructured":"Sessler CN, Varney K (2008) Patient-focused sedation and analgesia in the ICU. Chest 133(2):552\u201365. https:\/\/doi.org\/10.1378\/chest.07-2026","journal-title":"Chest"},{"issue":"1","key":"304_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","volume":"75","author":"AM Drewes","year":"2013","unstructured":"Drewes AM, Jensen RD, Nielsen LM et al (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol 75(1):60\u201378. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04317.x","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"304_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2215\/CJN.05180418","volume":"14","author":"SN Davison","year":"2019","unstructured":"Davison SN (2019) Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol 14(6):917\u2013931. https:\/\/doi.org\/10.2215\/CJN.05180418","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"304_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jcph.1276","volume":"58","author":"AN Nafziger","year":"2018","unstructured":"Nafziger AN, Barkin RL (2018) Opioid therapy in acute and chronic pain. J Clin Pharmacol 58(9):1111\u20131122. https:\/\/doi.org\/10.1002\/jcph.1276","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"304_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/bja\/aeu186","volume":"113","author":"R Klimas","year":"2014","unstructured":"Klimas R, Mikus G (2014) Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth 113(6):935\u201344. https:\/\/doi.org\/10.1093\/bja\/aeu186","journal-title":"Br J Anaesth"},{"issue":"12","key":"304_CR21","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/ndt\/12.12.2802","volume":"12","author":"B Bastani","year":"1997","unstructured":"Bastani B, Jamal JA (1997) Removal of morphine but not fentanyl during haemodialysis. Nephrol Dial Transplant 12(12):2802\u20134. https:\/\/doi.org\/10.1093\/ndt\/12.12.2802","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"304_CR22","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/00000542-200005000-00038","volume":"92","author":"MS Angst","year":"2000","unstructured":"Angst MS, B\u00fchrer M, L\u00f6tsch J (2000) Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action. Anesthesiology 92(5):1473\u20136","journal-title":"Anesthesiology"},{"issue":"6","key":"304_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/ndt\/13.6.1535","volume":"13","author":"JA Jamal","year":"1998","unstructured":"Jamal JA, Joh J, Bastani B (1998) Removal of morphine with the new high-efficiency and high-flux membranes during haemofiltration and haemodialfiltration. Nephrol Dial Transplant. 13(6):1535\u20137. https:\/\/doi.org\/10.1093\/ndt\/13.6.1535","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"304_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ccc.2009.03.003","volume":"25","author":"JW Devlin","year":"2009","unstructured":"Devlin JW, Roberts RJ (2009) Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin 25(3):431\u201349. https:\/\/doi.org\/10.1016\/j.ccc.2009.03.003","journal-title":"Crit Care Clin"},{"issue":"5","key":"304_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","volume":"17","author":"HE Bird","year":"2023","unstructured":"Bird HE, Huhn AS, Dunn KE (2023) Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl. J Addict Med 17(5):503\u2013508. https:\/\/doi.org\/10.1097\/ADM.0000000000001185","journal-title":"J Addict Med"},{"issue":"2","key":"304_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00000539-199802000-00049","volume":"86","author":"J Joh","year":"1998","unstructured":"Joh J, Sila MK, Bastani B (1998) Nondialyzability of fentanyl with high-efficiency and high-flux membranes. Anesth Analg 86(2):447. https:\/\/doi.org\/10.1097\/00000539-199802000-00049","journal-title":"Anesth Analg"},{"issue":"6","key":"304_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/EJA.0000000000001392","volume":"38","author":"KJ Polok","year":"2021","unstructured":"Polok KJ, Nowak-K\u00f3zka I, Fronczek J, Szczeklik W (2021) Concentrations of fentanyl before and after initiation of continuous venovenous haemodialysis in septic patients with acute kidney injury: a prospective observational study. Eur J Anaesthesiol 38(6):669\u2013671. https:\/\/doi.org\/10.1097\/EJA.0000000000001392","journal-title":"Eur J Anaesthesiol"},{"issue":"6","key":"304_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s00134-004-2224-6","volume":"30","author":"J Kountchev","year":"2004","unstructured":"Kountchev J, Bellmann R, Joannidis M (2004) Sufentanil in the ICU setting. Intensive Care Med 30(6):1244. https:\/\/doi.org\/10.1007\/s00134-004-2224-6","journal-title":"Intensive Care Med"},{"issue":"3","key":"304_CR29","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/cc4939","volume":"10","author":"B Muellejans","year":"2006","unstructured":"Muellejans B, Matthey T, Scholpp J, Schill M (2006) Sedation in the intensive care unit with remifentanil\/propofol versus midazolam\/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 10(3):R91","journal-title":"Crit Care"},{"issue":"1","key":"304_CR30","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1186\/cc2399","volume":"8","author":"D Breen","year":"2004","unstructured":"Breen D, Wilmer A, Bodenham A et al (2004) Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care. 8(1):R21-30. https:\/\/doi.org\/10.1186\/cc2399","journal-title":"Crit Care."},{"issue":"4","key":"304_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/bja\/aeh086","volume":"92","author":"M Pitsiu","year":"2004","unstructured":"Pitsiu M, Wilmer A, Bodenham A et al (2004) Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 92(4):493\u2013503. https:\/\/doi.org\/10.1093\/bja\/aeh086","journal-title":"Br J Anaesth"},{"issue":"7","key":"304_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00134-007-0574-6","volume":"33","author":"MP Bonnet","year":"2007","unstructured":"Bonnet MP, Minville V, Asehnoune K, Bridoux D, Poggi-Bach J, Duranteau J, Benhamou D (2007) Glycine and ammonia plasma concentrations during sedation with remifentanil in critically ill patients. Intensive Care Med 33(7):1179\u20131182. https:\/\/doi.org\/10.1007\/s00134-007-0574-6","journal-title":"Intensive Care Med"},{"key":"304_CR33","doi-asserted-by":"publisher","unstructured":"Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev. 2002;(1):CD003447. https:\/\/doi.org\/10.1002\/14651858.CD003447. Update in: Cochrane Database Syst Rev. 2013 Oct 25;(10):CD003447. https:\/\/doi.org\/10.1002\/14651858.CD003447.pub2","DOI":"10.1002\/14651858.CD003447"},{"issue":"3","key":"304_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0885-3924(94)00121-Z","volume":"10","author":"N Babul","year":"1995","unstructured":"Babul N, Darke AC, Hagen N (1995) Hydromorphone metabolite accumulation in renal failure. J Pain Symptom Manage 10(3):184\u20136. https:\/\/doi.org\/10.1016\/0885-3924(94)00121-Z","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"304_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.ajkd.2016.08.039","volume":"69","author":"HM Koncicki","year":"2017","unstructured":"Koncicki HM, Unruh M, Schell JO (2017) Pain management in CKD: a guide for nephrology providers. Am J Kidney Dis 69(3):451\u2013460. https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.039","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"304_CR36","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.pain.2013.08.015","volume":"154","author":"R Perlman","year":"2013","unstructured":"Perlman R, Giladi H, Brecht K, Ware MA, Hebert TE, Joseph L, Shir Y (2013) Intradialytic clearance of opioids: methadone versus hydromorphone. Pain 154(12):2794\u20132800. https:\/\/doi.org\/10.1016\/j.pain.2013.08.015","journal-title":"Pain"},{"issue":"949","key":"304_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","volume":"80","author":"R Brown","year":"2004","unstructured":"Brown R, Kraus C, Fleming M, Reddy S (2004) Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J 80(949):654\u20139. https:\/\/doi.org\/10.1136\/pgmj.2004.022988","journal-title":"Postgrad Med J"},{"issue":"2","key":"304_CR38","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/cc11250","volume":"16","author":"R Wanzuita","year":"2012","unstructured":"Wanzuita R, Poli-de-Figueiredo LF, Pfuetzenreiter F, Cavalcanti AB, Westphal GA (2012) Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial. Crit Care 16(2):R49. https:\/\/doi.org\/10.1186\/cc11250","journal-title":"Crit Care"},{"issue":"7","key":"304_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.clinthera.2015.04.009","volume":"37","author":"MS Opdal","year":"2015","unstructured":"Opdal MS, Arnesen M, M\u00fcller LD et al (2015) Effects of hemodialysis on methadone pharmacokinetics and QTc. Clin Ther 37(7):1594\u20139. https:\/\/doi.org\/10.1016\/j.clinthera.2015.04.009","journal-title":"Clin Ther"},{"issue":"6","key":"304_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2217\/pmt-2016-0002","volume":"6","author":"M Kohler","year":"2016","unstructured":"Kohler M, Chiu F, Gelber KM, Webb CA, Weyker PD (2016) Pain management in critically ill patients: a review of multimodal treatment options. Pain Manag 6(6):591\u2013602. https:\/\/doi.org\/10.2217\/pmt-2016-0002","journal-title":"Pain Manag"},{"key":"304_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcrc.2018.05.016","volume":"47","author":"SL Parker","year":"2018","unstructured":"Parker SL, Saxena M, Gowardman J, Lipman J, Myburgh J, Roberts JA (2018) Population pharmacokinetics of intravenous paracetamol in critically ill patients with traumatic brain injury. J Crit Care 47:15\u201320. https:\/\/doi.org\/10.1016\/j.jcrc.2018.05.016","journal-title":"J Crit Care"},{"key":"304_CR42","doi-asserted-by":"publisher","unstructured":"Gosselin S, Juurlink DN, Kielstein JT et al. Extrip Workgroup. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(8):856-67. https:\/\/doi.org\/10.3109\/15563650.2014.946994","DOI":"10.3109\/15563650.2014.946994"},{"issue":"6","key":"304_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/15563650.2016.1175006","volume":"54","author":"M Ghannoum","year":"2016","unstructured":"Ghannoum M, Kazim S, Grunbaum AM, Villeneuve E, Gosselin S (2016) Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clin Toxicol (Phila) 54(6):519\u201322. https:\/\/doi.org\/10.1080\/15563650.2016.1175006","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"304_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/15563650903524142","volume":"48","author":"TJ Wiegand","year":"2010","unstructured":"Wiegand TJ, Margaretten M, Olson KR (2010) Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol (Phila) 48(2):156\u20139. https:\/\/doi.org\/10.3109\/15563650903524142","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"304_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15563650.2017.1358366","volume":"56","author":"A Wong","year":"2018","unstructured":"Wong A, Tong RLK, Ryan L, Crozier T, Graudins A (2018) The use of sustained low efficiency dialysis (SLED) in massive paracetamol overdose. Clin Toxicol (Phila) 56(3):229\u2013231. https:\/\/doi.org\/10.1080\/15563650.2017.1358366","journal-title":"Clin Toxicol (Phila)"},{"issue":"9","key":"304_CR46","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3109\/15563650.2013.844824","volume":"51","author":"ML Sivilotti","year":"2013","unstructured":"Sivilotti ML, Juurlink DN, Garland JS, Lenga I, Poley R, Hanly LN, Thompson M (2013) Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila) 51(9):855\u201363. https:\/\/doi.org\/10.3109\/15563650.2013.844824","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"304_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","volume":"24","author":"C Sostres","year":"2010","unstructured":"Sostres C, Gargallo CJ, Arroyo MT, Lanas A (2010) Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24(2):121\u201332. https:\/\/doi.org\/10.1016\/j.bpg.2009.11.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"304_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/aca.ACA_239_18","volume":"23","author":"F Dastan","year":"2020","unstructured":"Dastan F, Langari ZM, Salamzadeh J, Khalili A, Aqajani S, Jahangirifard A (2020) A comparative study of the analgesic effects of intravenous ketorolac, paracetamol, and morphine in patients undergoing video-assisted thoracoscopic surgery: a double-blind, active-controlled, randomized clinical trial. Ann Card Anaesth 23(2):177\u2013182. https:\/\/doi.org\/10.4103\/aca.ACA_239_18","journal-title":"Ann Card Anaesth"},{"issue":"9","key":"304_CR49","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.clinthera.2009.08.026","volume":"31","author":"S Southworth","year":"2009","unstructured":"Southworth S, Peters J, Rock A, Pavliv L (2009) A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther 31(9):1922\u201335. https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.026","journal-title":"Clin Ther"},{"issue":"4","key":"304_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/157488410793352012","volume":"5","author":"D Cattaneo","year":"2010","unstructured":"Cattaneo D, Clementi E (2010) Clinical pharmacokinetics of ibuprofen arginine. Curr Clin Pharmacol 5(4):239\u201345. https:\/\/doi.org\/10.2174\/157488410793352012","journal-title":"Curr Clin Pharmacol"},{"issue":"2","key":"304_CR51","first-page":"155","volume":"6","author":"HO Senekjian","year":"1983","unstructured":"Senekjian HO, Lee CS, Kuo TH, Au DS, Krothapalli R (1983) Absorption and disposition of ibuprofen in hemodialyzed uremic patients. Eur J Rheumatol Inflamm 6(2):155\u201362","journal-title":"Eur J Rheumatol Inflamm"},{"key":"304_CR52","doi-asserted-by":"publisher","unstructured":"Brocks DR, Jamali F (1992) Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 23(6):415\u201327. https:\/\/doi.org\/10.2165\/00003088-199223060-00003. Erratum. In: Clin Pharmacokinet 1993 Mar; 24(3):270. Erratum in: Clin Pharmacokinet. 1993 Mar; 24(3):270. https:\/\/doi.org\/10.1007\/BF03259382","DOI":"10.2165\/00003088-199223060-00003"},{"issue":"7","key":"304_CR53","doi-asserted-by":"publisher","first-page":"e0157","DOI":"10.1097\/CCE.0000000000000157","volume":"2","author":"KE Wheeler","year":"2020","unstructured":"Wheeler KE, Grilli R, Centofanti JE et al (2020) Adjuvant analgesic use in the critically ill: a systematic review and meta-analysis. Crit Care Explor 2(7):e0157. https:\/\/doi.org\/10.1097\/CCE.0000000000000157","journal-title":"Crit Care Explor"},{"issue":"369","key":"304_CR54","doi-asserted-by":"publisher","first-page":"m1315","DOI":"10.1136\/bmj.m1315","volume":"28","author":"S Mathieson","year":"2020","unstructured":"Mathieson S, Lin CC, Underwood M, Eldabe S (2020) Pregabalin and gabapentin for pain. BMJ. 28(369):m1315. https:\/\/doi.org\/10.1136\/bmj.m1315","journal-title":"BMJ."},{"key":"304_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/JPR.S130942","volume":"10","author":"M Raouf","year":"2017","unstructured":"Raouf M, Atkinson TJ, Crumb MW, Fudin J (2017) Rational dosing of gabapentin and pregabalin in chronic kidney disease. J Pain Res 10:275\u2013278. https:\/\/doi.org\/10.2147\/JPR.S130942","journal-title":"J Pain Res"},{"key":"304_CR56","doi-asserted-by":"publisher","unstructured":"Bouchard J, Yates C, Calello DP, et al; EXTRIP Workgroup. Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. Am J Kidney Dis. 2022;79(1):88-104. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.027","DOI":"10.1053\/j.ajkd.2021.06.027"},{"issue":"1","key":"304_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clinthera.2011.12.004","volume":"34","author":"R Lal","year":"2012","unstructured":"Lal R, Sukbuntherng J, Luo W et al (2012) Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Clin Ther 34(1):201\u201313. https:\/\/doi.org\/10.1016\/j.clinthera.2011.12.004","journal-title":"Clin Ther"},{"issue":"3","key":"304_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0091270003251119","volume":"43","author":"EJ Randinitis","year":"2003","unstructured":"Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN (2003) Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 43(3):277\u201383. https:\/\/doi.org\/10.1177\/0091270003251119","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"304_CR59","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1053\/j.ajkd.2009.04.014","volume":"54","author":"L Yoo","year":"2009","unstructured":"Yoo L, Matalon D, Hoffman RS, Goldfarb DS (2009) Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure. Am J Kidney Dis 54(6):1127\u201330. https:\/\/doi.org\/10.1053\/j.ajkd.2009.04.014","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"304_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/0971-4065.83744","volume":"22","author":"AK Guddati","year":"2012","unstructured":"Guddati AK, Zafar Z, Cheng JT, Mohan S (2012) Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy. Indian J Nephrol 22(1):59\u201361. https:\/\/doi.org\/10.4103\/0971-4065.83744","journal-title":"Indian J Nephrol"},{"key":"304_CR61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.26502\/fjppr.086","volume":"7","author":"F Di Mario","year":"2023","unstructured":"Di Mario F, Galosi E, Greco P et al (2023) Therapeutic Drug Monitoring of Pregabalin in a Critically ill Patient with Acute Kidney Injury undergoing Continuous, Prolonged Intermittent, and Intermittent Kidney Replacement Therapy. J Pharm Pharmacol Res 7:220\u2013226. https:\/\/doi.org\/10.26502\/fjppr.086","journal-title":"J Pharm Pharmacol Res"},{"key":"304_CR62","doi-asserted-by":"publisher","unstructured":"Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;2014(4). https:\/\/doi.org\/10.1002\/14651858.CD005451.pub3","DOI":"10.1002\/14651858.CD005451.pub3"},{"issue":"1","key":"304_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","volume":"101","author":"CK Pandey","year":"2005","unstructured":"Pandey CK, Raza M, Tripathi M, Navkar DV, Kumar A, Singh UK (2005) The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barr\u00e9 syndrome patients in the intensive care unit. Anesth Analg 101(1):220\u20135. https:\/\/doi.org\/10.1213\/01.ANE.0000152186.89020.36","journal-title":"Anesth Analg"},{"key":"304_CR64","doi-asserted-by":"publisher","unstructured":"Ghannoum M, Yates C, Galvao TF, et al; EXTRIP workgroup. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(10):993-1004. https:\/\/doi.org\/10.3109\/15563650.2014.973572","DOI":"10.3109\/15563650.2014.973572"},{"issue":"3","key":"304_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1081\/clt-100100938","volume":"38","author":"DJ Schuerer","year":"2000","unstructured":"Schuerer DJ, Brophy PD, Maxvold NJ, Kudelka T, Bunchman TE (2000) High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 38(3):321\u20133. https:\/\/doi.org\/10.1081\/clt-100100938","journal-title":"J Toxicol Clin Toxicol"},{"issue":"6","key":"304_CR66","doi-asserted-by":"publisher","first-page":"484","DOI":"10.5414\/cnp57484","volume":"57","author":"JT Kielstein","year":"2002","unstructured":"Kielstein JT, Schwarz A, Arnavaz A, Sehlberg O, Emrich HM, Fliser D (2002) High-flux hemodialysis \u2013 an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 57(6):484\u20136. https:\/\/doi.org\/10.5414\/cnp57484","journal-title":"Clin Nephrol"},{"issue":"4","key":"304_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000335608","volume":"33","author":"A Azak","year":"2012","unstructured":"Azak A, Ko\u00e7ak G, Huddam B, Duranay M (2012) Is conventional hemodialysis enough to manage carbamazepine intoxication? Blood Purif 33(4):225\u20136. https:\/\/doi.org\/10.1159\/000335608","journal-title":"Blood Purif"},{"issue":"6","key":"304_CR68","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ajem.2017.10.048","volume":"36","author":"X Yang","year":"2018","unstructured":"Yang X, Xin S, Zhang Y, Li T (2018) Early hemoperfusion for emergency treatment of carbamazepine poisoning. Am J Emerg Med 36(6):926\u2013930. https:\/\/doi.org\/10.1016\/j.ajem.2017.10.048","journal-title":"Am J Emerg Med"},{"issue":"4","key":"304_CR69","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1191\/096032701678766831","volume":"20","author":"A Duzova","year":"2001","unstructured":"Duzova A, Baskin E, Usta Y, Ozen S (2001) Carbamazepine poisoning: treatment with plasma exchange. Hum Exp Toxicol 20(4):175\u20137. https:\/\/doi.org\/10.1191\/096032701678766831","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"304_CR70","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2018) Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 70(3):621\u2013660. https:\/\/doi.org\/10.1124\/pr.117.015198","journal-title":"Pharmacol Rev"},{"issue":"9","key":"304_CR71","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI (2016) Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet 55(9):1059\u201377","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"304_CR72","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s001340100965","volume":"27","author":"T Tsubo","year":"2001","unstructured":"Tsubo T, Sakai I, Okawa H, Ishihara H, Matsuki A (2001) Ketamine and midazolam kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome. Intensive Care Med 27(6):1087\u201390. https:\/\/doi.org\/10.1007\/s001340100965","journal-title":"Intensive Care Med"},{"issue":"1","key":"304_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1213\/00000539-197501000-00003","volume":"54","author":"MA Posner","year":"1975","unstructured":"Posner MA, Reves JG, Lell WA (1975) Aortic valve replacement in a hemodialysis-dependent patient: anesthetic considerations\u2013a case report. Anesth Analg. 54(1):24\u20138. https:\/\/doi.org\/10.1213\/00000539-197501000-00003","journal-title":"Anesth Analg."},{"issue":"8","key":"304_CR74","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","volume":"56","author":"MAS Weerink","year":"2017","unstructured":"Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P (2017) Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 56(8):893\u2013913. https:\/\/doi.org\/10.1007\/s40262-017-0507-7","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"304_CR75","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jcpt.12652","volume":"43","author":"W Zhong","year":"2018","unstructured":"Zhong W, Zhang Y, Zhang MZ et al (2018) Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia. J Clin Pharm Ther 43(3):414\u2013421. https:\/\/doi.org\/10.1111\/jcpt.12652","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"304_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12871-018-0472-1","volume":"18","author":"Y Liu","year":"2018","unstructured":"Liu Y, Sheng B, Wang S, Lu F, Zhen J, Chen W (2018) Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol 18(1):7. https:\/\/doi.org\/10.1186\/s12871-018-0472-1","journal-title":"BMC Anesthesiol"},{"issue":"2","key":"304_CR77","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0929867003375335","volume":"7","author":"G Trapani","year":"2000","unstructured":"Trapani G, Altomare C, Liso G, Sanna E, Biggio G (2000) Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 7(2):249\u201371. https:\/\/doi.org\/10.2174\/0929867003375335","journal-title":"Curr Med Chem"},{"issue":"4","key":"304_CR78","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00000542-200510000-00026","volume":"103","author":"MT Baker","year":"2005","unstructured":"Baker MT, Naguib M (2005) Propofol: The challenges of formulation. Anesthesiology 103(4):860\u201376. https:\/\/doi.org\/10.1097\/00000542-200510000-00026","journal-title":"Anesthesiology"},{"issue":"10","key":"304_CR79","doi-asserted-by":"publisher","first-page":"e30383","DOI":"10.7759\/cureus.30383","volume":"14","author":"A Singh","year":"2022","unstructured":"Singh A, Anjankar AP (2022) Propofol-Related Infusion Syndrome: A Clinical Review. Cureus. 14(10):e30383. https:\/\/doi.org\/10.7759\/cureus.30383","journal-title":"Cureus."},{"issue":"10","key":"304_CR80","doi-asserted-by":"publisher","first-page":"e46497","DOI":"10.7759\/cureus.46497","volume":"15","author":"S Van","year":"2023","unstructured":"Van S, Lam V, Patel K, Humphries A, Siddiqi J (2023) Propofol-Related Infusion Syndrome: A Bibliometric Analysis of the 100 Most-Cited Articles. Cureus. 15(10):e46497. https:\/\/doi.org\/10.7759\/cureus.46497","journal-title":"Cureus."},{"issue":"1","key":"304_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjms.2020.08.003","volume":"361","author":"S Samal","year":"2021","unstructured":"Samal S, Singhania N, Adl D, Afzal O, Singhania G (2021) Chocolate milk in CRRT circuit: propofol induced hypertriglyceridemia. Am J Med Sci 361(1):135\u2013136. https:\/\/doi.org\/10.1016\/j.amjms.2020.08.003","journal-title":"Am J Med Sci"},{"issue":"4","key":"304_CR82","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000528574","volume":"52","author":"BW Abramovitz","year":"2023","unstructured":"Abramovitz BW, Oguntuwase E, Abo-Zed A, DeSilva R (2023) Hypertriglyceridemia as a cause of continuous renal replacement therapy circuit clotting: a case series. Blood Purif 52(4):352\u2013358. https:\/\/doi.org\/10.1159\/000528574","journal-title":"Blood Purif"},{"issue":"7","key":"304_CR83","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","volume":"39","author":"E Sigel","year":"2018","unstructured":"Sigel E, Ernst M (2018) The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol Sci 39(7):659\u2013671. https:\/\/doi.org\/10.1016\/j.tips.2018.03.006","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"304_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","volume":"32","author":"EM Cornett","year":"2018","unstructured":"Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD (2018) New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol 32(2):149\u2013164. https:\/\/doi.org\/10.1016\/j.bpa.2018.06.007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"9","key":"304_CR85","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/CCM.0000000000002558","volume":"45","author":"SR Kudchadkar","year":"2017","unstructured":"Kudchadkar SR (2017) Benzodiazepines and delirium in the young and old: truth be told or still not sold? Crit Care Med 45(9):1562\u20131564. https:\/\/doi.org\/10.1097\/CCM.0000000000002558","journal-title":"Crit Care Med"},{"key":"304_CR86","doi-asserted-by":"publisher","unstructured":"Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151-60. https:\/\/doi.org\/10.1001\/jama.2012.304","DOI":"10.1001\/jama.2012.304"},{"issue":"8968","key":"304_CR87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0140-6736(95)91209-6","volume":"346","author":"TM Bauer","year":"1995","unstructured":"Bauer TM, Ritz R, Haberth\u00fcr C et al (1995) Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 346(8968):145\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(95)91209-6","journal-title":"Lancet"},{"issue":"1","key":"304_CR88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00134-011-2360-8","volume":"38","author":"CJ Kirwan","year":"2012","unstructured":"Kirwan CJ, MacPhee IA, Lee T, Holt DW, Philips BJ (2012) Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients. Intensive Care Med 38(1):76\u201384. https:\/\/doi.org\/10.1007\/s00134-011-2360-8","journal-title":"Intensive Care Med"},{"issue":"4","key":"304_CR89","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/cpt.1875","volume":"108","author":"EJ Egeland","year":"2020","unstructured":"Egeland EJ, Witczak BJ, Zar\u00e9 HK, Christensen H, \u00c5sberg A, Robertsen I (2020) Chronic inhibition of CYP3A is temporarily reduced by each hemodialysis session in patients with end-stage renal disease. Clin Pharmacol Ther 108(4):866\u2013873. https:\/\/doi.org\/10.1002\/cpt.1875","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"304_CR90","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/00912700122010933","volume":"41","author":"M Bolon","year":"2001","unstructured":"Bolon M, Bastien O, Flamens C, Paulus S, Boulieu R (2001) Midazolam disposition in patients undergoing continuous venovenous hemodialysis. J Clin Pharmacol 41(9):959\u201362. https:\/\/doi.org\/10.1177\/00912700122010933","journal-title":"J Clin Pharmacol"},{"key":"304_CR91","doi-asserted-by":"publisher","unstructured":"Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration. Am J Kidney Dis. 2005;45(2):360-71. https:\/\/doi.org\/10.1053\/j.ajkd.2004.09.004","DOI":"10.1053\/j.ajkd.2004.09.004"},{"issue":"2","key":"304_CR92","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000534538","volume":"53","author":"TJL Smeets","year":"2024","unstructured":"Smeets TJL, de Geus HRH, Valkenburg AJ et al (2024) The clearance of midazolam and metabolites during continuous renal replacement therapy in critically ill patients with COVID-19. Blood Purif 53(2):107\u2013113. https:\/\/doi.org\/10.1159\/000534538","journal-title":"Blood Purif"},{"issue":"4","key":"304_CR93","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jcph.2005","volume":"62","author":"KN Shudofsky","year":"2022","unstructured":"Shudofsky KN, Janssen PKC, Foudraine N, le Noble JLML (2022) Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome. J Clin Pharmacol. 62(4):568\u2013570. https:\/\/doi.org\/10.1002\/jcph.2005","journal-title":"J Clin Pharmacol."},{"issue":"5","key":"304_CR94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1365-2125.1981.tb01300.x","volume":"12","author":"RK Verbeeck","year":"1981","unstructured":"Verbeeck RK, Tjandramaga TB, De Schepper PJ, Verberckmoes R (1981) Impaired elimination of lorazepam following subchronic administration in two patients with renal failure. Br J Clin Pharmacol 12(5):749\u201351. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01300.x","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"304_CR95","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/cn5000056","volume":"5","author":"NE Calcaterra","year":"2014","unstructured":"Calcaterra NE, Barrow JC (2014) Classics in chemical neuroscience: diazepam (valium). ACS Chem Neurosci 5(4):253\u201360. https:\/\/doi.org\/10.1021\/cn5000056","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"304_CR96","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/00000539-200206000-00039","volume":"94","author":"AH Al-Khafaji","year":"2002","unstructured":"Al-Khafaji AH, Dewhirst WE, Manning HL (2002) Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis. Anesth Analg 94(6):1583\u20135. https:\/\/doi.org\/10.1097\/00000539-200206000-00039","journal-title":"Anesth Analg"},{"issue":"16","key":"304_CR97","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM200204183461618","volume":"346","author":"J Tayar","year":"2002","unstructured":"Tayar J, Jabbour G, Saggi SJ (2002) Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med 346(16):1253\u20134. https:\/\/doi.org\/10.1056\/NEJM200204183461618","journal-title":"N Engl J Med"},{"issue":"3","key":"304_CR98","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1378\/chest.128.3.1674","volume":"128","author":"KC Wilson","year":"2005","unstructured":"Wilson KC, Reardon C, Theodore AC, Farber HW (2005) Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 128(3):1674\u201381. https:\/\/doi.org\/10.1378\/chest.128.3.1674","journal-title":"Chest."},{"issue":"3","key":"304_CR99","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00280.x","volume":"20","author":"T Zar","year":"2007","unstructured":"Zar T, Graeber C, Perazella MA (2007) Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 20(3):217\u20139. https:\/\/doi.org\/10.1111\/j.1525-139X.2007.00280.x","journal-title":"Semin Dial."},{"issue":"10","key":"304_CR100","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-021-06503-1","volume":"47","author":"JL Stollings","year":"2021","unstructured":"Stollings JL, Kotfis K, Chanques G, Pun BT, Pandharipande PP, Ely EW (2021) Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med 47(10):1089\u20131103. https:\/\/doi.org\/10.1007\/s00134-021-06503-1","journal-title":"Intensive Care Med"},{"issue":"3","key":"304_CR101","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00134-003-2117-0","volume":"30","author":"YK Skrobik","year":"2004","unstructured":"Skrobik YK, Bergeron N, Dumont M, Gottfried SB (2004) Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 30(3):444\u20139. https:\/\/doi.org\/10.1007\/s00134-003-2117-0","journal-title":"Intensive Care Med"},{"issue":"1","key":"304_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12028-011-9643-3","volume":"16","author":"EH Wang","year":"2012","unstructured":"Wang EH, Mabasa VH, Loh GW, Ensom MH (2012) Haloperidol dosing strategies in the treatment of delirium in the critically ill. Neurocrit Care 16(1):170\u201383. https:\/\/doi.org\/10.1007\/s12028-011-9643-3","journal-title":"Neurocrit Care"},{"issue":"6","key":"304_CR103","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2165\/00003088-198917060-00004","volume":"17","author":"JS Froemming","year":"1989","unstructured":"Froemming JS, Lam YW, Jann MW, Davis CM (1989) Pharmacokinetics of haloperidol. Clin Pharmacokinet 17(6):396\u2013423. https:\/\/doi.org\/10.2165\/00003088-198917060-00004","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"304_CR104","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","volume":"38","author":"JW Devlin","year":"2010","unstructured":"Devlin JW, Roberts RJ, Fong JJ et al (2010) Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 38(2):419\u201327. https:\/\/doi.org\/10.1097\/CCM.0b013e3181b9e302","journal-title":"Crit Care Med"},{"issue":"7","key":"304_CR105","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","volume":"40","author":"CL DeVane","year":"2001","unstructured":"DeVane CL, Nemeroff CB (2001) Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 40(7):509\u201322. https:\/\/doi.org\/10.2165\/00003088-200140070-00003","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"304_CR106","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/0391398819837686","volume":"42","author":"L Giuntoli","year":"2019","unstructured":"Giuntoli L, Dalmastri V, Cilloni N et al (2019) Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent. Int J Artif Organs. 42(9):516\u2013520. https:\/\/doi.org\/10.1177\/0391398819837686","journal-title":"Int J Artif Organs."},{"issue":"4","key":"304_CR107","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/15563650.2012.665456","volume":"50","author":"L Lannemyr","year":"2012","unstructured":"Lannemyr L, Knudsen K (2012) Severe overdose of quetiapine treated successfully with extracorporeal life support. Clin Toxicol (Phila) 50(4):258\u201361. https:\/\/doi.org\/10.3109\/15563650.2012.665456","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"304_CR108","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/ALN.0b013e31825153cc","volume":"116","author":"SM Hakim","year":"2012","unstructured":"Hakim SM, Othman AI, Naoum DO (2012) Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology 116(5):987\u201397. https:\/\/doi.org\/10.1097\/ALN.0b013e31825153cc","journal-title":"Anesthesiology"},{"issue":"6","key":"304_CR109","doi-asserted-by":"publisher","first-page":"404","DOI":"10.9740\/mhc.2019.11.404","volume":"9","author":"R Tourtellotte","year":"2019","unstructured":"Tourtellotte R, Schmidt R (2019) Use of therapeutic drug monitoring of risperidone microspheres long-acting injection in hemodialysis: a case report. Ment Health Clin 9(6):404\u2013407. https:\/\/doi.org\/10.9740\/mhc.2019.11.404","journal-title":"Ment Health Clin"},{"issue":"2","key":"304_CR110","doi-asserted-by":"publisher","first-page":"17l02212","DOI":"10.4088\/PCC.17l02212","volume":"20","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Narang P, Lippman S (2018) Injectable risperidone during hemodialysis. Prim Care Companion CNS Disord 20(2):17l02212. https:\/\/doi.org\/10.4088\/PCC.17l02212","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"304_CR111","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/JCP.0b013e3181c827c4","volume":"30","author":"A Batalla","year":"2010","unstructured":"Batalla A, Vera M, Torra M, Parellada E (2010) Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis. J Clin Psychopharmacol 30(1):92\u20134. https:\/\/doi.org\/10.1097\/JCP.0b013e3181c827c4","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-025-00304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-025-00304-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-025-00304-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:04:54Z","timestamp":1763417094000},"score":1,"resource":{"primary":{"URL":"https:\/\/janesthanalgcritcare.biomedcentral.com\/articles\/10.1186\/s44158-025-00304-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1186\/s44158-025-00304-4","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}